A Study to Learn More About How Well Aficamten Works in Japanese Participants With Symptomatic Obstructive Hypertrophic Cardiomyopathy
Clinical trial NCT07023341 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT07023341
- Sponsor
- Bayer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-06-30
- Primary completion
- 2026-08-31
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.